As Seen In

Interesting Engineering: The future of medicine could lie in organoid research

RegMedNet: Advancing multiple sclerosis with cerebral organoids: an interview with Nicolas Daviaud

The New Yorker: A New Approach to MS Could Transform Treatment of Other Diseases

Neurology Live: Intrathecal Mesenchymal Stem Cells are Potential Treatment for Progressive Multiple Sclerosis: Saud A. Sadiq, MD, FAAN

MS News Today: AAN 2023: MSC-NP aids walking in advanced progressive MS patients

BioInformant: FDA-Approved Phase II Stem Cell Treatment Trial Shows Significant and Diverse Improvements for Multiple Sclerosis (MS) Patients

New Scientist: Stem cell therapy reduces symptoms of progressive MS for some people

Neuro Rehab Times: New hope for potential MS treatment

Neuro Rehab Times: 'Mini brains' shed new light on MS

RegMedNet: Microglia may be a therapeutic target of mesenchymal stem cell-derived neural progenitor therapy.

MS News Today: Stem cell therapy MSC-NP can ease inflammatory activity in brain cells

Managed Healthcare Executive: Researchers Develop 'Mini-Brain' Model That Could Help Identify Targets for MS Treatment

National MS Society:New Study Shows How Primary Progressive MS May Differ from Other Forms of MS

Mini-brain’ models point to poorer oligodendrocyte growth in PPMS

Primary Progressive MS confirmed as own disorder in mouse study

Primary progressive multiple sclerosis is a distinct disease (

Top 10 ALS Stories of 2022

BioSpace: Highlighted by Amylyx, the ALS Space is Gaining Momentum 

Managed Healthcare Executive:COVID-19 Vaccination and People with MS: T Cells Boosted, Antibdies Not So Much.

ALS News Today: Cholesterol Transporter May Be Stronger Trigger of Sporadic ALS 

RealTalk MS Podcast: Interview with Tisch MSRCNY Scientist, Dr. Roberto Alfonso

Mice injected with spinal fluid from ALS patients offer potential therapeutic target

When spinal fluid from ALS patients was put into mice, the mice got weak. An unlikely protein could be the culprit

Brain Communications: Apolipoprotein B-100-mediated motor neuron degeneration in sporadic amyotrophic lateral sclerosis

MS News Today: Anti-CD20 Therapies Help Mount T-cell Response to COVID-19 Vaccines

Frontiers in Immunology: Strong T-cell activation in response to CVOID-19 vaccination in multiple sclerosis patients receiving B-cell depleting therapies

Stem Cells Treatments Show Promise in MS (

RealTalk MS Podcast: Episode 250 featuring Dr. Saud Sadiq

Biospace: Research Shows Stem Cells Might Become a Game Changer for Multiple Sclerosis 

CNN: Jamie-Lynn Sigler is sorry to dash your ‘Sopranos’ reboot hopes

CBS Evening News Segment Featuring Tisch MS.

FOX5 News The Big Idea: Multiple Sclerosis Clinical Trial Shows Promise 

The Joan Hamburg Show Director and Chief Research Scientist of the Tisch MS Research Center of New York, Dr. Saud A. Sadiq, talks with Joan Hamburg about MS and our Phase II stem cell trial. 

Dr. Saud A. Sadiq Speaks About the Tisch MSRCNY Stem Cell Trial on NY1 During National MS Awareness Month.

Wheelchair Kamikaze - An Interview with Dr. Sadiq on Phase II of the Stem Cell Trial 

MStranslates Interview with Dr. Violaine Harris Dr. Violaine Harris - Senior Research Scientist at Tisch MS Research Center of New York talks to Brett Drummond from MStranslates about the stem cell trial. 

Bioinformant - Stem Cell Therapy Shows Promise for Treatment of MS - Q&A with Dr. Sadiq of Tisch MSRCNY 

NY Mag: Dr. Sadiq-Damage Control 


Tisch MS Research Center of New York

521 West 57th Street
4th Floor
New York, NY 10019
(646) 557-3900

Privacy Policy


Support Tisch MS

Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.